CRIS Current Research Information System

PASQUALI, RENATO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.385
AS - Asia 8.510
EU - Europa 7.853
SA - Sud America 691
AF - Africa 489
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 9
Totale 29.952
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.260
GB - Regno Unito 2.370
SG - Singapore 2.347
VN - Vietnam 2.262
CN - Cina 2.170
IT - Italia 1.051
DE - Germania 947
SE - Svezia 891
FR - Francia 597
HK - Hong Kong 583
BR - Brasile 530
RU - Federazione Russa 482
UA - Ucraina 470
IN - India 454
IE - Irlanda 283
ZA - Sudafrica 214
JP - Giappone 163
EE - Estonia 162
FI - Finlandia 120
CH - Svizzera 114
TG - Togo 108
NL - Olanda 90
KR - Corea 89
AR - Argentina 66
BG - Bulgaria 65
CI - Costa d'Avorio 59
CA - Canada 58
PH - Filippine 55
BE - Belgio 49
BD - Bangladesh 44
IQ - Iraq 43
SC - Seychelles 36
MX - Messico 35
JO - Giordania 34
AT - Austria 32
ID - Indonesia 32
TH - Thailandia 31
EC - Ecuador 30
TR - Turchia 28
GR - Grecia 26
PK - Pakistan 24
NG - Nigeria 23
IR - Iran 22
SA - Arabia Saudita 21
ES - Italia 20
PL - Polonia 20
TW - Taiwan 20
UZ - Uzbekistan 19
CL - Cile 18
PY - Paraguay 16
LB - Libano 14
AU - Australia 12
MY - Malesia 12
RO - Romania 12
MA - Marocco 11
CO - Colombia 10
EG - Egitto 9
HN - Honduras 9
PE - Perù 9
PT - Portogallo 9
CZ - Repubblica Ceca 8
KZ - Kazakistan 8
VE - Venezuela 8
HR - Croazia 7
AE - Emirati Arabi Uniti 6
AL - Albania 6
ET - Etiopia 6
EU - Europa 6
TN - Tunisia 6
LT - Lituania 5
BZ - Belize 4
DO - Repubblica Dominicana 4
KG - Kirghizistan 4
MD - Moldavia 4
SN - Senegal 4
CY - Cipro 3
DZ - Algeria 3
GE - Georgia 3
IL - Israele 3
KW - Kuwait 3
NO - Norvegia 3
NP - Nepal 3
NZ - Nuova Zelanda 3
PA - Panama 3
RS - Serbia 3
TT - Trinidad e Tobago 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BF - Burkina Faso 2
CR - Costa Rica 2
JM - Giamaica 2
LV - Lettonia 2
NI - Nicaragua 2
PS - Palestinian Territory 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
AO - Angola 1
BH - Bahrain 1
BO - Bolivia 1
BW - Botswana 1
CG - Congo 1
Totale 29.932
Salva come PNG Salva come JPEG
Città #
Southend 2.131
Ashburn 1.561
Singapore 1.510
Fairfield 1.492
Woodbridge 711
Wilmington 676
Seattle 663
Chandler 660
Houston 603
Hong Kong 555
San Jose 482
Cambridge 472
Santa Clara 435
Princeton 415
Dong Ket 410
Ho Chi Minh City 408
Ann Arbor 373
Hanoi 349
Jacksonville 306
Dublin 281
Beijing 278
Boardman 240
Bologna 236
Lauterbourg 214
Nanjing 200
Westminster 194
Padova 181
Hefei 167
Tokyo 148
Los Angeles 140
Berlin 122
Lomé 108
Shenyang 106
Buffalo 105
Saint Petersburg 100
Helsinki 98
Jinan 97
Bern 92
San Diego 91
New York 90
Haiphong 69
Seoul 66
Guangzhou 64
Nanchang 64
Sofia 64
Changsha 61
Mülheim 61
Redondo Beach 60
Abidjan 59
Milan 59
Hebei 57
Da Nang 55
Dallas 54
Tianjin 54
Shanghai 49
São Paulo 49
Bremen 46
Council Bluffs 43
Redwood City 39
The Dalles 39
Brussels 38
Chicago 38
Turin 38
Falls Church 36
Dearborn 34
Frankfurt am Main 34
Jiaxing 34
Norwalk 34
Olalla 34
Amman 32
Hangzhou 32
Zhengzhou 32
Medford 31
Redmond 31
Yubileyny 30
Munich 29
Can Tho 28
Des Moines 27
Orem 26
Rome 26
Johannesburg 25
Mahé 25
Phoenix 24
Haikou 23
Abeokuta 22
Florence 21
Taizhou 21
London 20
Naples 20
Ningbo 20
Taiyuan 20
Verona 20
Vienna 20
Xi'an 20
Baghdad 19
Ha Long 19
San Venanzo 19
Lanzhou 18
Rio de Janeiro 18
Toronto 18
Totale 19.668
Salva come PNG Salva come JPEG
Nome #
Treatment of obesity in polycystic ovary syndrome: a position statement of the Androgen Excess and Polycystic Ovary Syndrome Society 571
Predictors of weight loss and maintenance in patients treated with antiobesity drugs. 509
Defining hyperandrogenism in women with polycystic ovary syndrome: A challenging perspective 286
Centenarians’ offspring as a model of healthy aging: a reappraisal of the data on Italian subjects and a comprehensive overview 268
Behavioral, socio-environmental, educational and demographic correlates of excess body weight in Italian adolescents and young adults 261
Can imaging predict subclinical cortisol secretion in patients with adrenal adenomas? A CT predictive score 246
Insulin sensitizers in polycystic ovary syndrome 243
Heterogeneity of thyroid function and impact of peripheral thyroxine deiodination in centenarians and semi-supercentenarians: association with functional status and mortality. 243
Active and total ghrelin concentrations in the newborn 236
Il sistema endocannabinoide e il controllo del metabolismo energetico: fisiologia e fisiopatologia 232
Cardiovascular events and mortality in patients with adrenal incidentalomas that are either non-secreting or associated with intermediate phenotype or subclinical Cushing's syndrome: a 15-year retrospective study. 229
Body mass index-independent metabolic alterations in narcolepsy with cataplexy. 226
Aldosterone and type 2 diabetes mellitus 226
Clomiphene citrate effect in obese men with low serum testosterone treated with metformin due to dysmetabolic disorders: A randomized, double-blind, placebo-controlled study 226
Androgen Profiling by Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) in Healthy Normal-Weight Ovulatory and Anovulatory Late Adolescent and Young Women 223
Acyl ghrelin and metabolic hormones in pregnant and lactating sows. 223
Steroid biomarkers for identifying non-classic adrenal hyperplasia due to 21-hydroxylase deficiency in a population of PCOS with suspicious levels of 17OH-progesterone 223
The potential role of increased adrenal volume in the pathophysiology of obesity-related type 2 diabetes. 222
Plasma 2-arachidonoylglycerol is a biomarker of age and menopause related insulin resistance and dyslipidemia in lean but not in obese men and women 221
Profiling plasma N-Acylethanolamine levels and their ratios as a biomarker of obesity and dysmetabolism 221
Acute severe male hypo-testosteronemia affects central motor command in humans 220
17-hydroxyprogesterone responses to gonadotropin-releasing hormone disclose distinct phenotypes of functional ovarian hyperandrogenism and polycystic ovary syndrome. 218
Whole Exome Sequencing Uncovers Germline Variants of Cancer-Related Genes in Sporadic Pheochromocytoma 218
Combined Aldosterone and Cortisol Secretion by Adrenal Incidentaloma 216
11C-meta-hydroxyephedrine PET/CT imaging allows in vivo study of adaptive thermogenesis and white-to-brown fat conversion 216
CB(1) signaling in forebrain and sympathetic neurons is a key determinant of endocannabinoid actions on energy balance. 215
New insights on diabetes in Turner syndrome: results from an observational study in adulthood 215
Dietary habits and their relationship with hormones and metabolism in overweight and obese women with polycystic ovary syndrome 214
A combination of polymorphisms in HSD11B1 associates with in vivo 11{beta}-HSD1 activity and metabolic syndrome in women with and without polycystic ovary syndrome. 210
The Steroid Profile of Adrenal Incidentalomas: Subtyping Subjects With High Cardiovascular Risk 205
Endocrine dysfunction in hereditary hemochromatosis 198
A comprehensive approach in diagnosing the polycystic ovary syndrome 195
A new interaction to come: Ghrelin and steroid hormones 192
A placebo controlled, randomized clinical trial using testosterone undecanoate with injectable norethisterone enanthate: effects on anthropometric, metabolic and biochemical parameters 189
Cortisol, energy intake, and food frequency in overweight/obese women 185
Anti-müllerian hormone and insulin-like 3 levels in healthy normal-weight ovulatory and anovulatory eumenorrheic late adolescent females: potential early biomarkers of ovarian dysfunction? 184
The negative association between total ghrelin levels, body mass and insulin secretion is lost in hypercortisolemic patients with Cushing's disease. 182
Treatment with flutamide, metformin, and their combination added to a hypocaloric diet in overweight-obese women with polycystic ovary syndrome: a randomized, 12-month, placebo-controlled study. 182
Cross-talk between adipose tissue and the HPA axis in obesity and overt hypercortisolemic states 181
Short-term modification of sex hormones is associated with changes in ghrelin circulating levels in healthy normal-weight men. 180
Psychological aspects of hyperandrogenic states in late adolescent and young women. 180
Circulating endocannabinoids are differentially modulated during the oral glucose tolerance test 179
Salivary cortisol and cortisone responses to short-term psychological stress challenge in late adolescent and young women with different hyperandrogenic states 179
The endocannabinoid system and the treatment of obesity. 176
Obesity-related proliferative diseases: The interaction between adipose tissue and estrogens in post-menopausal women 176
The empowerment of translational research: lessons from laminopathies. 175
Tablet and oral liquid L-thyroxine formulation in the treatment of naive hypothyroid patients with Helicobacter pylori infection 175
Cannabinoid type 1 receptor: another arrow in the adipocytes' bow 174
Clinical assessment of allostatic overload in adolescent and young women with hyperandrogenic states 173
Organic cation transporter 1 polymorphisms predict the metabolic response to metformin in women with the polycystic ovary syndrome. 172
The Significance of Low Testosterone Levels in Obese Men 172
Relationships between total and regional adiposity and epicardial fat in obese women: how can dual-energy X-ray absorptiometry be associated with echocardiographic epicardial fat measurements? 168
Polycystic ovary syndrome is a risk factor for type 2 diabetes: results from a long-term prospective study. 168
Cannabinoid type 1 receptor blockade promotes mitochondrial biogenesis through endothelial nitric oxide synthase expression in white adipocytes 167
Effect of flutamide and metformin administered alone or in combination in dieting obese women with polycystic ovary syndrome. 167
Energy balance regulation by endocannabinoids at central and peripheral levels 166
Adrenal adenomas, subclinical hypercortisolism, and cardiovascular outcomes 163
Improving the diagnosis of 11β-hydroxylase deficiency using home-made MLPA probes: identification of a novel chimeric CYP11B2/CYP11B1 gene in a Sicilian patient 163
Effect of clomiphene citrate treatment on the Sertoli cells of dysmetabolic obese men with low testosterone levels 163
Fighting obesity and associated risk factors by antagonising cannabinoid type 1 receptors. 162
Common variants in the sex hormone-binding globulin gene (SHBG) and polycystic ovary syndrome (PCOS) in Mediterranean women. 162
EFFECT OF FASTING AND REFEEDING ON PLASMA GHRELIN LEVELS IN PREPUBERTAL GILTS 162
Genetic variation in 11beta-hydroxysteroid dehydrogenase type 1 predicts adrenal hyperandrogenism among lean women with polycystic ovary syndrome. 161
Abdominal adiposity by ultrasonography: a "pocket" database for reference standard in Italian people 160
In vivo dissolution of levothyroxine soft gel capsules 160
Tissue-specific dysregulation of 11β-hydroxysteroid dehydrogenase type 1 in overweight/obese women with polycystic ovary syndrome compared with weight-matched controls 159
Prominent role of low HDL-cholesterol in explaining the high prevalence of the metabolic syndrome in polycystic ovary syndrome. 159
Le aree cerebrali ed i neurotrasmettitori deputati al senso di sazietà, piacere e dipendenza: quale ruolo nel mantenimento dell'obesità? 158
Assessment of the awareness and management of sleep apnea syndrome in acromegaly. The COM.E.TA (Comorbidities Evaluation and Treatment in Acromegaly) Italian Study Group 157
Plasma adiponectin in non alcoholic fatty liver disease is related to hepatic fat content and hepatic insulin resistance, not to liver disease severity 156
Circulating obestatin levels and the grelin/obestatin ratio in obese women 156
Serum steroid profiling by isotopic dilution-liquid chromatography-mass spectrometry: comparison with current immunoassays and reference intervals in healthy adults. 156
Monogenic polycystic ovary syndrome due to a mutation in the lamin A/C gene is sensitive to thiazolidinediones but not to metformin 155
Hirsutism and virilization 155
Plasma acylated ghrelin levels are higher in patients with chronic atrophic gastritis. 155
La surrenectomia laparoscopica: le dimensioni della lesione costituiscono un limite all'approccio mini-invasivo? 153
Role of sex hormones in modulation of brown adipose tissue activity 153
Stress-related development of obesity and cortisol in women 153
Is there a dose-response relationship of metformin treatment in patients with polycystic ovary syndrome? Results from a multicentric study. 153
Cannabinoid receptors as therapeutic targets for obesity and metabolic diseases. 153
Increased clearance of cortisol by 5beta-reductase in a subgroup of women with adrenal hyperandrogenism in polycystic ovary syndrome. 153
Radiological formula for differentiating between secreting and non secreting adrenal adenomas. 153
Requirement of cannabinoid receptor type 1 for the basal modulation of hypothalamic-pituitary-adrenal axis function. 152
No metabolic impact of surgical normalization of hyperandrogenism in postmenopausal women with ovarian androgen-secreting tumours 152
Prescription medications for the treatment of obesity 149
Cannabinoid receptor antagonists and the metabolic syndrome: Novel promising therapeutical approaches. 149
Obesity, fat distribution and infertility. 148
Familial partial lipodystrophy, mandibuloacral dysplasia and restrictive dermopathy feature barrier-to-autointegration factor (BAF) nuclear redistribution 148
Metabolic alterations and cardiovascular risk factors in the polycystic ovary syndrome. 147
Metabolic effects of obesity on reproduction. 147
Revisiting hyper- and hypo-androgenism by tandem mass spectrometry. 147
Sindrome dell'ovaio policistico e diabete di tipo 2 146
Basal insulin-like factor 3 levels predict functional ovarian hyperandrogenism in the polycystic ovary syndrome. 145
Obesity and androgens: facts and perspectives. 144
Glucose intolerance in a large cohort of mediterranean women with polycystic ovary syndrome: phenotype and associated factors 144
Parallel variations of insulin-like peptide 3 (INSL3) and antimüllerian hormone (AMH) in women with the polycystic ovary syndrome according to menstrual cycle pattern. 143
Insulin-like factor 3: a new circulating hormone related to luteinizing hormone-dependent ovarian hyperandrogenism in the polycystic ovary syndrome. 142
Ghrelin and reproductive disorders. 142
High serum concentration of total inhibin in polycystic ovary syndrome 141
Formula radiologica per differenziare adenomi surrenalici secernenti e non secernenti 141
Totale 18.837
Salva come PNG Salva come JPEG
Categoria #
all - tutte 80.580
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 80.580
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.211 0 0 0 0 0 0 0 0 0 191 140 880
2021/20223.732 386 148 250 307 320 204 94 249 123 249 831 571
2022/20233.381 421 477 168 478 182 209 102 170 542 217 248 167
2023/20241.362 101 167 64 44 63 164 256 359 20 57 43 24
2024/20253.414 134 695 336 226 675 200 205 72 41 133 81 616
2025/20267.587 585 723 797 677 964 565 875 308 1.597 496 0 0
Totale 30.382